2015
DOI: 10.3389/fsurg.2015.00026
|View full text |Cite
|
Sign up to set email alerts
|

Expression of Cathepsins B, D, and G in Infantile Hemangioma

Abstract: AimsThe role of the renin–angiotensin system (RAS) in the biology of infantile hemangioma (IH) represents an emerging paradigm, particularly the involvement of renin, angiotensin converting enzyme, and angiotensin II. This study investigated the expression of cathepsins B, D, and G, enzymes that may modulate the RAS, in IH.Materials and MethodsThe expression of cathepsins B, D, and G was examined using immunohistochemistry, enzyme activity assays, mass spectrometry, and NanoString gene expression assay in IH s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
24
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
1
1

Relationship

3
5

Authors

Journals

citations
Cited by 25 publications
(26 citation statements)
references
References 30 publications
2
24
0
Order By: Relevance
“…Total protein extraction, digestion, and mass spectrometry were performed as described previously ( 24 ). Briefly, snap-frozen proliferating ( n = 2) and involuted ( n = 2) IH tissues from the same cohorts used for IHC staining were homogenized with a Dounce Homogenizer (Thomas Co., Philadelphia, PA, USA) in ice-cold RIPA buffer (Sigma-Aldrich, St. Louis, MA, USA) containing Complete Protease inhibitor (Roche Life Science, Penzberg, Germany), and after quantitation (Qubit ® 2.0 Fluorometer, Life Technologies, San Diego, CA, USA), 100 mg of total protein per sample was precipitated overnight at −20°C (ProteoExtract ® Protein Precipitation Kit, Merck Millipore, Billerica, MA, USA).…”
Section: Methodsmentioning
confidence: 99%
“…Total protein extraction, digestion, and mass spectrometry were performed as described previously ( 24 ). Briefly, snap-frozen proliferating ( n = 2) and involuted ( n = 2) IH tissues from the same cohorts used for IHC staining were homogenized with a Dounce Homogenizer (Thomas Co., Philadelphia, PA, USA) in ice-cold RIPA buffer (Sigma-Aldrich, St. Louis, MA, USA) containing Complete Protease inhibitor (Roche Life Science, Penzberg, Germany), and after quantitation (Qubit ® 2.0 Fluorometer, Life Technologies, San Diego, CA, USA), 100 mg of total protein per sample was precipitated overnight at −20°C (ProteoExtract ® Protein Precipitation Kit, Merck Millipore, Billerica, MA, USA).…”
Section: Methodsmentioning
confidence: 99%
“…The precise nature of these cells requires further investigation. This localization of functionally active cathepsins B and D suggests the presence of RAS bypass loops in these CSCs, similar to IH, 32 glioblastoma, 36 oral tongue SCC, 37 and metastatic colon adenocarcinoma. 38 …”
Section: Discussionmentioning
confidence: 66%
“…The production of the peptides of the RAS involves many alternative signaling pathways, including enzymes such as cathepsins B, D, and G. 32 Cathepsin B is a lysosomal cysteine protease that processes that cleaves inactive prorenin to renin. 33 Cathepsin D is an aspartyl protease that converts angiotensinogen to ATI, and is functionally homologous to renin.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…2016) with positive effects. The understanding of the regulation of the RAS and CSCs in GB, in particular the expression and function of cathepsin B (Itinteang, Chudakova et al 2015) and the IGF/IGFR-1 pathway (Al Hassan, Fakhoury et al 2018) lead us to propose modulating the RAS, a singular systemic homeostatic pathway, using a combination of drugs (Figure 1), to simultaneously inhibit key steps of the RAS, its bypass loops and crosstalk signaling pathways interacting with the RAS, may offer a novel therapeutic approach for patients with GB (Roth, Wickremesekera et al 2019),…”
Section: Repurposing Drugs That Target the Rasmentioning
confidence: 99%